pyrazines has been researched along with Hepatic Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaratnam, G; Dixon, S; Green, M; Lehrer-Graiwer, J; Marbury, T; Preston, RA; Washington, C | 1 |
| Bergman, AJ; Davies, MJ; Dilzer, SC; Herman, GA; Lasseter, KC; Luo, WL; Migoya, EM; Stevens, CH; Wagner, JA | 1 |
2 trial(s) available for pyrazines and Hepatic Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment.
Topics: Adult; Aged; Area Under Curve; Benzaldehydes; Body Mass Index; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Half-Life; Hematologic Agents; Hepatic Insufficiency; Humans; Male; Middle Aged; Pyrazines; Pyrazoles; Renal Insufficiency | 2021 |
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin.
Topics: Administration, Oral; Aged; Area Under Curve; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Half-Life; Hepatic Insufficiency; Humans; Liver Function Tests; Male; Middle Aged; Pyrazines; Severity of Illness Index; Sitagliptin Phosphate; Triazoles | 2009 |